Results 251 to 260 of about 101,972,928 (277)

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Stroke care in Germany: evidence gaps and priorities for health services research and quality assurance. [PDF]

open access: yesNeurol Res Pract
Wiegand FN   +19 more
europepmc   +1 more source

Author Correction: CBX4 stabilizes NEUROD1 through SUMO-ubiquitin crosstalk to delay β-cell senescence. [PDF]

open access: yesNat Commun
Su L   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy